AU5279093A - Process for production of cell cultures with elevated content of endogenous cytokines - Google Patents

Process for production of cell cultures with elevated content of endogenous cytokines

Info

Publication number
AU5279093A
AU5279093A AU52790/93A AU5279093A AU5279093A AU 5279093 A AU5279093 A AU 5279093A AU 52790/93 A AU52790/93 A AU 52790/93A AU 5279093 A AU5279093 A AU 5279093A AU 5279093 A AU5279093 A AU 5279093A
Authority
AU
Australia
Prior art keywords
cell cultures
production
elevated content
endogenous cytokines
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU52790/93A
Other versions
AU672449B2 (en
Inventor
Horst Kief
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6476762&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU5279093(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of AU5279093A publication Critical patent/AU5279093A/en
Application granted granted Critical
Publication of AU672449B2 publication Critical patent/AU672449B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons

Abstract

The process entails exposing cultures of patient's autologous blood to an ozone/oxygen mixture and fractionating. The cell cultures are cultivated in a manner known per se and lysates are added as stimulants. The lysates are obtained by ozonolysis and proteolysis of blood or blood fractions and/or urine.
AU52790/93A 1992-12-29 1993-12-24 Process for production of cell cultures with elevated content of endogenous cytokines Ceased AU672449B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4244437.3 1992-12-29
DE4244437A DE4244437A1 (en) 1992-12-29 1992-12-29 Process for obtaining the body's own cytokines

Publications (2)

Publication Number Publication Date
AU5279093A true AU5279093A (en) 1994-07-14
AU672449B2 AU672449B2 (en) 1996-10-03

Family

ID=6476762

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52790/93A Ceased AU672449B2 (en) 1992-12-29 1993-12-24 Process for production of cell cultures with elevated content of endogenous cytokines

Country Status (8)

Country Link
EP (1) EP0607593B1 (en)
JP (1) JPH0787965A (en)
AT (1) ATE196088T1 (en)
AU (1) AU672449B2 (en)
CA (1) CA2112314A1 (en)
DE (2) DE4244437A1 (en)
ES (1) ES2151895T3 (en)
ZA (1) ZA939718B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19903876B4 (en) * 1999-02-01 2006-09-28 Orthogen Gentechnologie Gmbh Process for the in vitro formation and accumulation of interleukin-1 receptor antagonists
US6303154B1 (en) 1999-09-24 2001-10-16 Boris Breivogel Chemical alteration of mammal urine and mammal blood
EP1555026A3 (en) * 2000-04-26 2005-12-07 Breivogel, Boris Chemical modification of mammalian blood
EP1278530B1 (en) * 2000-04-26 2005-06-15 Boris Breivogel Chemical modification of mammalian urine
DE102006005016A1 (en) * 2006-02-03 2007-08-16 Orthogen Ag Conditioned blood composition and process for its preparation
WO2008077638A1 (en) * 2006-12-22 2008-07-03 Horst Kief Whole blood cultures comprising stimulated immune cells, and use thereof as medicaments
EP2829278A1 (en) 2013-07-23 2015-01-28 Scientific BioTech GmbH Serum for the treatment of diseases
ITMI20131667A1 (en) 2013-10-09 2015-04-10 Ind Paolo Gobbi Frattini METHOD TO PRE-TREAT THE HEMATIC CELLS BEFORE SEPARATION.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2017618B3 (en) * 1986-10-30 1991-03-01 Horst Kief PROCEDURE TO PRODUCE SUBSTANCES THAT HAVE THEIR GERMS KILLED OR THAT ARE WEAKENED IN THEIR VIRULENCE, AS WELL AS THE USE OF THE SAME
CA2015294A1 (en) * 1989-04-28 1990-10-28 John J. Rinehart Generation and expansion of lak cells

Also Published As

Publication number Publication date
ATE196088T1 (en) 2000-09-15
ZA939718B (en) 1994-08-29
EP0607593B1 (en) 2000-09-06
ES2151895T3 (en) 2001-01-16
DE4244437A1 (en) 1994-07-28
DE59310100D1 (en) 2000-10-12
CA2112314A1 (en) 1994-06-30
EP0607593A3 (en) 1994-12-14
EP0607593A2 (en) 1994-07-27
JPH0787965A (en) 1995-04-04
AU672449B2 (en) 1996-10-03

Similar Documents

Publication Publication Date Title
HUT47977A (en) Polipeptides, process for their production and process for production of medical compositions containing such active substances
ATE95560T1 (en) FERMENTATION PROCESS AND APPARATUS.
PT85285A (en) Process for producing il-6 and of pharmaceutical compositions containing the same
ATE78053T1 (en) SIMPLIFIED PROCEDURE FOR PRODUCTION OF HUMAN LYMPHOKINE-INACTIVATED KILLER CELLS.
AU588837B2 (en) Polypeptide
CA2017379A1 (en) Purification and characterization of a glioma-derived growth factor
AU5279093A (en) Process for production of cell cultures with elevated content of endogenous cytokines
AU1553388A (en) Treatment of diabetes
DE69427955T2 (en) Process for the preparation of 2,2-difluoroketene silyl acetals and alpha, alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid esters
JPS57170186A (en) Perfectly synthetic cell culture medium
AU587144B2 (en) Use of medetomidine compounds for treatment of anxiety disorders
ATE61793T1 (en) AMINO ACID ESTERS OF CYCLOALIPHATIC ALCOHOLS, PROCESS FOR THE PREPARATION AND USE AS A MEDICINAL PRODUCT.
EP0461921A3 (en) Method for the biological preparation of hydroxyvitamin d compounds
CA2028893A1 (en) Morpholinols, their prepation and use
HUT69990A (en) Method and composition for determining the immunological activity of bioactive substances
ATE83480T1 (en) CYCLIC PEPTIDE, ITS PRODUCTION AND USE IN THE TREATMENT OF CARDIOVASCULAR DISORDERS.
ATE45675T1 (en) USE OF INTERFERON GAMMA (IFN-GAMMA) IN THE MANUFACTURE OF PREPARATIONS FOR THE TREATMENT OF RHEUMATIC DISEASES.
DE3681629D1 (en) CHOLESTEROL-Rich Fraction, Process For This, And Use Of The Same For Cell Culture.
DE3884741D1 (en) Microbiological process for the preparation of UK-61.689 and microorganisms for use therein.
CA2064774A1 (en) Culture methods for producing activated protein c
GB8709470D0 (en) Immobilised cells
DE69019431T2 (en) Use of 15-keto-prostanoic acid derivatives for the manufacture of a medicament for improving the excretion of potassium ion.
ATE69268T1 (en) PROCESS FOR THE PREPARATION OF 4-ANDROSTENE-3,17-DIONE AND 1,4-ANDROSTADIA-3,17-DIONE.
JPS57181695A (en) Production of heterophile antibody

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired